VivoSeq
Other

Respiratory Insufficiency

7

Pipeline Programs↗

1

Active Trials↗

6

Companies Involved↗

Respiratory insufficiency is an early-stage landscape with 7 programs across 6 companies. The most active players are Gilead, Boehringer Ingelheim, Mylan Pharma UK Ltd.. 3 therapies are approved.

Intelligence

Pipeline Metrics

Competitive Density

32/100

Pipeline Velocity

0/100

Mech. Concentration

20/100

Completion Rate

67/100

Attrition Rate

20/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Gilead logo

Gilead

1 program

Phase 2Boehringer Ingelheim logo

Boehringer Ingelheim

1 program

Phase 2M

Mylan Pharma UK Ltd.

1 program

Phase 2F

Fresenius Kabi Oncology Ltd.

1 program

ApprovedM

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

1 program

ApprovedN

Noorik Biopharmaceuticals AG

0 programs

Preclinical

Pipeline

Programs by Phase

Analysis

Trial Status

5

clinical trials

Completed2 · 40%
Terminated1 · 20%
Unknown status1 · 20%
Recruiting1 · 20%

Clinical Trials

Trial Activity

A Study of Micro Dose Ambrisentan in Hospitalized Patients With Respiratory Insufficiency Due to COVID-19
Terminated·NNoorik Biopharmaceuticals AG·Phase 2·NCT04771000·88 enrolled
Senicapoc in COVID-19 Patients With Severe Respiratory Insufficiency
Unknown status·UUniversity of Aarhus·Phase 2·NCT04594668·46 enrolled
Revefenacin in Acute Respiratory Insufficiency in COPD
Completed·UUniversity of California, Los Angeles·Phase 2·NCT04315558·21 enrolled
Validation of a Non-Invasive Device for Thoracoabdominal Asynchrony-Based Respiratory Effort Assessment in Pediatric Patients
Recruiting·MMassachusetts General Hospital·Preclinical·NCT04626154·20 enrolled
Diaphragm Injury and Dysfunction During Mechanical Ventilation
Completed·UUniversity Health Network, Toronto·N/A·NCT03108118·50 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)